Publications by authors named "Giulia Laterza"

Ever since its discovery, human immunodeficiency virus type 1 (HIV-1) infection has remained a significant public health concern. The number of HIV-1 seropositive individuals currently stands at 40.1 million, yet definitive treatment for the virus is still unavailable on the market.

View Article and Find Full Text PDF

is an emergent zoonotic agent associated with multidrug resistance (MDR). This work aimed to describe the antibacterial activity of four essential oils (EOs) and silver nanoparticles (AgNPs) against 15 strains isolated from pyoderma. The four EOs, namely (RO), (GI), (AR), and (AB), and AgNPs were used alone and in combination to determine the Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC).

View Article and Find Full Text PDF
Article Synopsis
  • Commensal bacteria are commonly found in food, water, and on the skin of humans and animals, but they can also act as significant pathogens causing various illnesses and are considered highly resistant to antibiotics.
  • The CDC identifies these bacteria as some of the most dangerous due to their virulence and contribution to antimicrobial resistance (AMR) threats.
  • Research using a large collection of bacterial isolates reveals variations in antibiotic resistance patterns based on source and geographic location, emphasizing the need for a One Health approach to better understand and manage these infections across human and animal populations.
View Article and Find Full Text PDF

Contagious pathogens are very costly to dairy herds, and they may have zoonotic and reverse-zoonotic potentials and may contribute to the spread of antimicrobial resistance. One of the most important risk factors for spreading these infections is milking, when liner contamination may transfer the pathogens from infected to healthy cows. There is no effective protocol to prevent the transmission of infection without the segregation of infected cows.

View Article and Find Full Text PDF
Article Synopsis
  • The text discusses a prevalent bacterial pathogen that affects both humans and animals, causing various illnesses like food poisoning and respiratory infections, in addition to animal health issues like mastitis and dermatitis.
  • It highlights the emergence of virulent and drug-resistant strains, particularly methicillin-resistant varieties (MRSA), which pose serious health risks due to high mortality and hospitalization rates.
  • The study utilized a global database to analyze antibiotic resistance genes, revealing alarming patterns of resistance in both humans and animals, and identifying specific clusters related to different sources of infection.
View Article and Find Full Text PDF

Mastitis is a major cause of antimicrobial treatments either during lactation or at drying off. From a One Health perspective, there should be a balance between the risk of IMI that may impair cow health and welfare and the reduction of antimicrobial usage to decrease antimicrobial resistance, as may happen when applying selective dry-cow therapy. This reduction may be achieved by an early and accurate diagnosis followed by prudent and rationale therapeutical protocols.

View Article and Find Full Text PDF

is a well-known pathogen in humans and food-producing animals. Therefore, this bacterium is a paradigmatic example of a pathogen to be controlled by a One Health approach. Indeed, the zoonotic and reverse-zoonotic potential of the bacteria, the prevalence of Group B Streptococci (GBS) diseases in both human and animal domains, and the threatening global situation on GBS antibiotic resistance make these bacteria an important target for control programs.

View Article and Find Full Text PDF